Skip to content

Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function

Gentamicin Treatment Prior to Vestibular Schwannoma Surgery in Patients With no Measurable Remaining Vestibular Function

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02415257
Enrollment
0
Registered
2015-04-14
Start date
2015-04-30
Completion date
2020-09-30
Last updated
2020-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular Schwannoma

Keywords

Vestibular schwannoma, acoustic neuroma, cerebellopontine angle tumour, gentamicin, rehabilitation, postural balance

Brief summary

The purpose of the study is to determine whether vestibular and postural compensation following schwannoma surgery is improved by ablating vestibular function prior to surgery, even if vestibular function is absent according to modern assessment techniques

Detailed description

Patients subjected to vestibular schwannoma surgery most often suffer from vertigo after surgery, even if no vestibular function can be found in pre-surgical assessment. According to retrospective data about 33% of patients scheduled for surgery do not have any measurable vestibular function. Even the occurrence of spontaneous nystagmus has been recorded in patients with no or very little function prior to surgery (Parietti-Winkler et al. 2008 JNNP). This indicates that despite new methods of measuring vestibular function, remaining vestibular function can be present and patients might benefit from pre-treatment of gentamicin (Tjernström et al. 2009 JNNP)

Interventions

DRUGGentamicin

Intratympanic installation of gentamicin 2-4 times depending on the efficacy of vestibular deafferentation

Sponsors

Lund University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Vestibular schwannoma advised to surgical treatment * No measurable remaining vestibular function

Exclusion criteria

* impaired decision making * neurofibromatosis * signs for central dysfunction * remaining vestibular function * Patients are advised not to participate in the gentamicin arm if * hearing is better than 30 deciBel (dB) in pure tone average (500, 1000, 2000, 3-4000 Hz) and speech discrimination better than 70% * the neurosurgeon aim at hearing preservation surgery and do not want to risk gentamicin associated hearing loss

Design outcomes

Primary

MeasureTime frameDescription
Differences and changes of postural control following surgery, compared to before surgeryAt first vestibular assessment at the time for inclusion and 6 months after surgeryPostural control assessed with posturography during a sensory conflict

Secondary

MeasureTime frameDescription
Occurrence of spontaneous nystagmus after surgeryDay 1 after surgery and for the duration of either spontaneous nystagmus or hospital stay (up to 2 weeks)To measure spontaneous nystagmus and its direction after surgery as a sign of vestibular deafferentation or central nervous damage
Change of hearing levelsAt first vestibular assessment and 4weeks after gentamicin installationMeasuring hearing levels (pure tone average and speech discrimination) before and after gentamicin treatment to determine possible detrimental effects on hearing
Differences in the level of stress after surgeryDaily after surgery for the duration of the hospital stay, up to 2 weeksMeasuring cortisol in the saliva after surgery during the time patients are admitted to the hospital
Differences of subjective well being after surgeryImmediate time after surgery (2weeks)Daily subjective assessment of perceived vertigo/dizziness after surgery
Differences of duration of hospital stayAfter surgery for the duration of the hospital stay up to 2 weeksLength of hospital stay required before patients can be discharged
Differences of subjective well being after gentamicin treatmentImmediate time after gentamicin treatment (2weeks)Daily subjective assessment of perceived vertigo/dizziness after gentamicin treatment
Differences of perceived anxiety/depression after surgery6 months after surgeryMeasurement of level of anxiety/depression in daily life, questionnaire Hospital Anxiety and Depression Scale (HADS)
Change of level of perceived dizziness after surgery as compared to before surgeryAt first vestibular assessment (inclusion) and 6 months after surgeryMeasurement of level of dizziness in daily life, questionnaire Dizziness Handicap Inventory (DHI)
Change of level of perceived anxiety/depression after surgery as compared to before surgeryAt first vestibular assessment (inclusion) and 6 months after surgeryMeasurement of level of anxiety/depression in daily life, questionnaire Hospital Anxiety and Depression Scale (HADS)
Differences in vestibular compensation after surgery6 months after surgeryVestibular function tests; v-HIT (head impulse test), calorics and otolith tests to determine compensation and function after surgery
Change of vestibular function after gentamicin treatment6 weeks after gentamicin treatmentVestibular function tests; v-HIT (head impulse test), calorics and otolith tests to determine compensation and function after gentamicin treatment
Differences of perceived dizziness after surgery6 months after surgeryMeasurement of level of dizziness in daily life, questionnaire Dizziness Handicap Inventory (DHI)

Other

MeasureTime frameDescription
Differences of needed sick-leave from work and leisure activities6 months after surgeryTime for return to normal daily activities after surgery, both job-related and leisure.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026